9,375,000 Shares of Common Stock ($0.001 Par Value) Warrants to Purchase up to 4,218,750 Shares of Common Stock SCYNEXIS, Inc. Common Stock EQUITY UNDERWRITING AGREEMENTEquity Underwriting Agreement • June 22nd, 2016 • Scynexis Inc • Pharmaceutical preparations • New York
SCYNEXIS, Inc., a Delaware corporation (the “Issuer”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom Guggenheim Securities, LLC is acting as representative (“you” or the “Representative”) an aggregate of (i) 9,375,000 shares of the Issuer’s Common Stock, $0.001 par value (the “Firm Shares”) and (ii) warrants, each of which can be exercised to purchase .45 of a share of Common Stock and, in the aggregate, to purchase up to 4,218,750 shares of Common Stock (the “Firm Warrants” and, together with the Firm Shares, the “Firm Securities”) in the form attached hereto as Exhibit A. The respective amounts of the Firm Securities to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto. The Issuer also proposes to sell at the Underwriters’ option an aggregate of (i) up to 1,406,250 additional shares of the Issuer’s Common Stock (the “Option Shares” and, together with the Firm Shares, the “Shares”
